Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial
Year: 2025
Type: article
Language: en
Topic: Advanced Breast Cancer Therapies
Authors and affiliations:
raw_author_name: K.L. Jhaveri
raw_affiliation_strings: Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: jhaverik@mskcc.org
Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: jhaverik@mskcc.org
raw_author_name: P. Neven
raw_affiliation_strings: University Hospitals Leuven, Louvain, Belgium
raw_author_name: M.L. Casalnuovo
raw_affiliation_strings: Hospital Maria Curie, Buenos Aires, Argentina
raw_author_name: S.-B. Kim
raw_affiliation_strings: Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
raw_author_name: E. Tokunaga
raw_affiliation_strings: Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
raw_author_name: P. Aftimos
raw_affiliation_strings: Institut Jules Bordet, Brussels, Belgium
raw_author_name: C. Saura
raw_affiliation_strings: Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: J. O’Shaughnessy
raw_affiliation_strings: Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX, USA
raw_author_name: N. Harbeck
raw_affiliation_strings: Breast Center, Department of OB&GYN, LMU University Hospital, Munich, Germany
Breast Center, Dept. OB&GYN, LMU University Hospital, Munich, Germany
raw_author_name: L.A. Carey
raw_affiliation_strings: University of North Carolina at Chapel Hill, Chapel Hill, USA
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
raw_author_name: G. Curigliano
raw_affiliation_strings: Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy; European Institute of Oncology, IRCCS, Milan, Italy
Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy; European Institute of Oncology, IRCCS, Milano, Italy
raw_author_name: J. Watanabe
raw_affiliation_strings: Juntendo University Graduate School of Medicine, Tokyo, Japan
Juntendo University Graduate School of Medicine, Bunkyo, Tokyo, Japan
raw_author_name: E. Lim
raw_affiliation_strings: Garvan Institute of Med Research, Darlinghurst, Australia
raw_author_name: J. Huang
raw_affiliation_strings: Xiangya Hospital Central South University, Changsha, China
Xiangya Hospital Central South University, Changsha, Hunan, 410008 China
raw_author_name: Z. Qingyuan
raw_affiliation_strings: Harbin Medical University Cancer Hospital, Harbin, China
raw_author_name: A. Llombart-Cussac
raw_affiliation_strings: Hospital Arnau Villanova, Universidad CEU Cardenal-Herrera, Valencia, Spain
raw_author_name: C. Huang
raw_affiliation_strings: National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
raw_author_name: B. Desai
raw_affiliation_strings: Eli Lilly and Company, Indianapolis, USA
Eli Lilly and Company, Indianapolis, IN, USA
raw_author_name: Y. Limay
raw_affiliation_strings: Eli Lilly and Company, Indianapolis, USA
Eli Lilly and Company, Indianapolis, IN, USA
raw_author_name: X.A. Wang
raw_affiliation_strings: Eli Lilly and Company, Indianapolis, USA
Eli Lilly and Company, Indianapolis, IN, USA
raw_author_name: S. Cao
raw_affiliation_strings: Eli Lilly and Company, Indianapolis, USA
Eli Lilly and Company, Indianapolis, IN, USA
raw_author_name: F.C. Bidard
raw_affiliation_strings: Institut Curie and Université Paris-Saclay, UVSQ, Paris, France